Patrick Garnero
#126,837
Most Influential Person Now
Researcher
Patrick Garnero's AcademicInfluence.com Rankings
Patrick Garnerocomputer-science Degrees
Computer Science
#5376
World Rank
#5681
Historical Rank
Machine Learning
#1401
World Rank
#1423
Historical Rank
Artificial Intelligence
#1634
World Rank
#1665
Historical Rank
Database
#2527
World Rank
#2648
Historical Rank
Download Badge
Computer Science
Patrick Garnero's Degrees
- Masters Computer Science Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Patrick Garnero Influential?
(Suggest an Edit or Addition)Patrick Garnero's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Body mass index as a predictor of fracture risk: A meta-analysis (2005) (1439)
- A meta-analysis of previous fracture and subsequent fracture risk. (2004) (1162)
- The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. (2003) (1083)
- Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study (1996) (996)
- Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis (1996) (992)
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards (2011) (915)
- The role of collagen in bone strength (2005) (911)
- Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. (1994) (737)
- Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study (2000) (702)
- The Use of Biochemical Markers of Bone Turnover in Osteoporosis (2000) (688)
- The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases* (1998) (602)
- Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate (2003) (596)
- Combined Calcium and Vitamin D3 Supplementation in Elderly Women: Confirmation of Reversal of Secondary Hyperparathyroidism and Hip Fracture Risk: The Decalyos II Study (2002) (552)
- The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen Degradation (2003) (435)
- Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. (1997) (425)
- Change in Bone Turnover and Hip, Non‐Spine, and Vertebral Fracture in Alendronate‐Treated Women: The Fracture Intervention Trial (2004) (387)
- Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. (1993) (384)
- Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage (2001) (382)
- Identification of Osteopenic Women at High Risk of Fracture: The OFELY Study (2005) (373)
- Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. (2006) (364)
- Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. (1996) (359)
- Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown. (2005) (317)
- Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. (2000) (316)
- Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. (2002) (307)
- Apparent Pre‐ and Postmenopausal Bone Loss Evaluated by DXA at Different Skeletal Sites in Women: The OFELY Cohort (1997) (300)
- Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. (2000) (298)
- Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. (2011) (285)
- Collagen type II C-telopeptide fragments as an index of cartilage degradation. (2001) (283)
- Pentosidine and increased fracture risk in older adults with type 2 diabetes. (2009) (281)
- Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. (2001) (279)
- Markers of Bone Turnover Predict Postmenopausal Forearm Bone Loss Over 4 Years: The OFELY Study (1999) (254)
- The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults. (2003) (253)
- Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. (2003) (252)
- Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173] (2005) (244)
- Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid (2008) (243)
- Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro (1994) (233)
- Markers of bone turnover for the management of patients with bone metastases from prostate cancer (2000) (225)
- Different effects of bisphosphonate and estrogen therapy on free and peptide‐bound bone cross‐links excretion (1995) (222)
- Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis (2010) (220)
- Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women (1995) (203)
- Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. (2002) (200)
- The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. (2006) (198)
- Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women (2000) (197)
- Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. (1994) (195)
- Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlle (2010) (194)
- Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. (2001) (191)
- Biochemical Indices of Bone Turnover and the Assessment of Fracture Probability (2002) (187)
- Measurement of serum osteocalcin with a human‐specific two‐site immunoradiometric assay (1992) (183)
- Non-enzymatic Glycation of Bone Collagen Modifies Osteoclastic Activity and Differentiation* (2007) (182)
- Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. (2007) (179)
- Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. (2006) (173)
- Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention Trial (2005) (173)
- Biochemical Markers of Bone Turnover and Prediction of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures (1999) (172)
- Increased Dickkopf-1 expression in breast cancer bone metastases (2007) (170)
- In Vivo Assessment of Architecture and Micro-Finite Element Analysis Derived Indices of Mechanical Properties of Trabecular Bone in the Radius (2002) (170)
- Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY study (1996) (170)
- Markers of Bone Turnover for the Prediction of Fracture Risk (2000) (168)
- Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study. (2005) (163)
- The multiple facets of periostin in bone metabolism (2012) (162)
- Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. (2000) (154)
- Immunoassay of pyridinoline crosslink excretion in normal adults and in paget's disease (1993) (152)
- Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States (2009) (149)
- Markers of bone turnover in hyperthyroidism and the effects of treatment. (1994) (148)
- Increased bone resorption in moderate smokers with low body weight: the Minos study. (2002) (148)
- Rapid and robust response of biochemical markers of bone formation to teriparatide therapy. (2009) (148)
- Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. (2004) (146)
- Do Markers of Bone Resorption Add to Bone Mineral Density and Ultrasonographic Heel Measurement for the Prediction of Hip Fracture in Elderly Women? The EPIDOS Prospective Study (1998) (146)
- Establishing a reference range for bone turnover markers in young, healthy women. (2008) (145)
- Effect of Fracture on Bone Turnover Markers: A Longitudinal Study Comparing Marker Levels Before and After Injury in 113 Elderly Women (2007) (143)
- Lack of Correlation Between Start Codon Polymorphism of the Vitamin D Receptor Gene and Bone Mineral Density in Premenopausal French Women: The OFELY Study (1998) (143)
- Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. (2008) (143)
- Genetic influence on bone turnover in postmenopausal twins. (1996) (142)
- Measurement of Bone Degradation Products in Serum Using Antibodies Reactive with an Isomerized Form of an 8 Amino Acid Sequence of the C‐Telopeptide of Type I Collagen (1997) (139)
- Biochemical markers of bone turnover. Applications for osteoporosis. (1998) (138)
- Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. (2009) (138)
- Collagen Iα1 Sp1 Polymorphism, Bone Mass, and Bone Turnover in Healthy French Premenopausal Women: The OFELY Study (1998) (133)
- Longitudinal Study of Bone Loss in Pre- and Perimenopausal Women: Evidence for Bone Loss in Perimenopausal Women (2000) (129)
- Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study (2013) (128)
- Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis. (2006) (127)
- Periostin action in bone (2016) (127)
- Monitoring individual response to hormone replacement therapy with bone markers. (2000) (126)
- Type I Collagen Racemization and Isomerization and the Risk of Fracture in Postmenopausal Women: The OFELY Prospective Study (2002) (125)
- Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment (2005) (125)
- Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis (2007) (125)
- Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. (2002) (123)
- Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers (2009) (123)
- Cross‐Sectional Evaluation of Bone Metabolism in Men * (2001) (121)
- Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis (2003) (121)
- New developments in biological markers of bone metabolism in osteoporosis. (2014) (120)
- A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression. (2007) (116)
- Decreased bone turnover in oral contraceptive users. (1995) (114)
- ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors (2011) (113)
- Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS Study (2009) (112)
- Biomarkers for Osteoporosis Management (2008) (110)
- Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. (2004) (109)
- Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH* Cohort (2005) (107)
- Treatment of Postmenopausal Women with Osteoporosis or Low Bone Density with Raloxifene (1999) (107)
- Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study (2005) (106)
- Prognostic value of PINP, bone alkaline phosphatase, CTX‐I, and YKL‐40 in patients with metastatic prostate carcinoma (2006) (103)
- Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study (2007) (102)
- Decreased β‐Isomerization of the C‐Terminal Telopeptide of Type I Collagen α1 Chain in Paget's Disease of Bone (1997) (101)
- Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. (2005) (99)
- A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. (2001) (99)
- Serum Estradiol and Sex Hormone‐Binding Globulin and the Risk of Hip Fracture in Elderly Women: The EPIDOS Study (2000) (97)
- Risk factors for hip fracture in women with high BMD: EPIDOS study (2005) (96)
- Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. (2005) (96)
- Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover. (2000) (95)
- Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. (2004) (95)
- Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis. (2012) (91)
- Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiog (2011) (91)
- Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial (2008) (90)
- The contribution of collagen crosslinks to bone strength. (2012) (90)
- Effects of a New Selective Estrogen Receptor Modulator (MDL 103,323) on Cancellous and Cortical Bone in Ovariectomized Ewes: A Biochemical, Histomorphometric, and Densitometric Study (2001) (89)
- Effects of Oral Alendronate on BMD in Adult Patients With Osteogenesis Imperfecta: A 3‐Year Randomized Placebo‐Controlled Trial (2005) (88)
- Consensus on the utility of bone markers in the malignant bone disease setting. (2011) (87)
- Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products. (1999) (87)
- Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial. (2008) (87)
- The Role of Collagen Organization on the Properties of Bone (2015) (86)
- Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study. (2004) (85)
- Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral density. (2005) (85)
- Biomarkers in osteoarthritis (2003) (84)
- Serum leptin as a determinant of bone resorption in healthy postmenopausal women. (2003) (83)
- Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men (2005) (81)
- Circulating Dickkopf-1 and Radiological Progression in Patients with Early Rheumatoid Arthritis Treated with Etanercept (2008) (81)
- A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover. (1999) (80)
- Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? (2015) (80)
- Increased expression and serum levels of the stromal cell‐secreted protein periostin in breast cancer bone metastases (2011) (79)
- Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women. (2009) (79)
- The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis (2010) (77)
- Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. (1998) (76)
- Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate: Review of Statistical Analysis (2007) (76)
- Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. (2008) (75)
- Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence (2011) (74)
- Serum protein signatures detect early radiographic osteoarthritis. (2009) (74)
- Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study. (2007) (74)
- Biological markers in osteoarthritis. (2012) (72)
- Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis (2007) (72)
- Reference intervals of bone turnover markers in healthy premenopausal women: results from a cross-sectional European study. (2012) (72)
- Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women. (1999) (71)
- The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone. (2001) (70)
- A Combination of Low Doses of 17β-Estradiol and Norethisterone Acetate Prevents Bone Loss and Normalizes Bone Turnover in Postmenopausal Women (2000) (70)
- Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis (2004) (69)
- Long‐Term Variability of Markers of Bone Turnover in Postmenopausal Women and Implications for Their Clinical Use: The OFELY Study (2003) (69)
- Accuracies of Serum and Fecal S100 Proteins (Calprotectin and Calgranulin C) to Predict the Response to TNF Antagonists in Patients with Crohn's Disease (2015) (69)
- The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation. (2008) (66)
- Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation (2006) (66)
- Bone markers in osteoporosis (2009) (65)
- Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY study. (2014) (64)
- Is bone quality associated with collagen age? (2009) (64)
- Consumption of a high calcium mineral water lowers biochemical indices of bone remodeling in postmenopausal women with low calcium intake (2005) (64)
- Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study (2010) (63)
- The Utility of Biomarkers in Osteoporosis Management (2017) (63)
- New automated multiplex assay for bone turnover markers in osteoporosis. (2008) (63)
- Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis (2006) (63)
- Markers of bone turnover in prostate cancer. (2001) (62)
- Short-term effects of corticosteroids on trabecular bone remodeling in old ewes. (1997) (62)
- Monitoring cartilage turnover (2007) (61)
- Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis. (2008) (61)
- Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradation. (2001) (60)
- A dose-ranging trial of a matrix transdermal 17β-estradiol for the prevention of bone loss in early postmenopausal women (1999) (59)
- Changes of Biochemical Markers of Bone Turnover and YKL-40 Following Hormonal Treatment for Metastatic Prostate Cancer Are Related to Survival (2007) (58)
- Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline. (2002) (58)
- New developments in biochemical markers for osteoporosis (2009) (57)
- Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis (2005) (56)
- Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls. (2006) (56)
- Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses. (2007) (55)
- Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases. (2007) (55)
- Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers. (2001) (54)
- Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study. (2003) (53)
- Opposite relationships between circulating Dkk-1 and cartilage breakdown in patients with rheumatoid arthritis and knee osteoarthritis (2009) (53)
- Can biochemical markers serve as surrogates for imaging in knee osteoarthritis? (2007) (52)
- Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study. (2003) (52)
- Platelet is a major contributor to circulating levels of Dickkopf‐1: clinical implications in patients with multiple myeloma (2009) (51)
- First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro (2010) (51)
- Use of biochemical markers to study and follow patients with osteoarthritis (2006) (51)
- Reappraisal of OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: The OMERACT 9 v2 Criteria (2009) (51)
- The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis (2004) (50)
- Periostin Deficiency Increases Bone Damage and Impairs Injury Response to Fatigue Loading in Adult Mice (2013) (48)
- A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma (2009) (48)
- Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY study. (2002) (47)
- Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis. (2012) (47)
- Correlates of knee pain in younger subjects (2006) (47)
- Pharmacological effects of tiludronate in horses after long-term immobilization. (2007) (46)
- A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs (2009) (43)
- Biochemical markers of bone formation reflect endosteal bone loss in elderly men--MINOS study. (2005) (43)
- Quantification of immature and mature collagen crosslinks by liquid chromatography-electrospray ionization mass spectrometry in connective tissues. (2010) (42)
- Assessment of Circulating Dickkopf-1 with a New Two-Site Immunoassay in Healthy Subjects and Women with Breast Cancer and Bone Metastases (2009) (42)
- Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers (2004) (41)
- Proposal for Levels of Evidence Schema for Validation of a Soluble Biomarker Reflecting Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, and Recommendations for Study Design (2009) (41)
- An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis. (2002) (41)
- Potential contribution of IL-17-producing Th(1)cells to defective repair activity in joint inflammation: partial correction with Th(2)-promoting conditions. (2001) (39)
- Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations. (2009) (37)
- Recommendations for monitoring antiresorptive therapies in postmenopausal osteoporosis. (2005) (37)
- Periostin and transforming growth factor β‐induced protein (TGFβIp) are both expressed by osteoblasts and osteoclasts (2014) (37)
- Investigation of Bone Disease Using Isomerized and Racemized Fragments of Type I Collagen (2002) (35)
- Effects of PTH and Alendronate on Type I Collagen Isomerization in Postmenopausal Women With Osteoporosis: The PaTH Study (2008) (35)
- The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover (2009) (35)
- Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide. (2004) (35)
- Biochemical markers of joint tissue turnover in early rheumatoid arthritis. (2003) (34)
- [Biochemical markers of bone turnover : clinical usefulness in osteoporosis]. (1999) (33)
- Intraocular pressure changes and alterations in intracranial pressure (2000) (33)
- Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials. (2007) (31)
- Biochemical Markers of Bone Turnover in the Clinical Development of Drugs for Osteoporosis and Metastatic Bone Disease (2012) (31)
- Osteocalcin–insulin relationship in obese children: a role for the skeleton in energy metabolism (2011) (30)
- Clinical utility of serum bone turnover markers in postmenopausal osteoporosis therapy monitoring: a systematic review. (2011) (28)
- Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: the OFELY study. (2015) (28)
- Cathepsin K Preferentially Solubilizes Matured Bone Matrix (2012) (28)
- Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: a literature review. (2013) (28)
- Developing a toolkit for the assessment and monitoring of musculoskeletal ageing (2018) (27)
- 4 Bone markers (1997) (26)
- Vasostatin-I, a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinetics, and prognostic significance (2012) (25)
- Bone markers. (1997) (25)
- Comparative pharmacokinetics of two intravenous administration regimens of tiludronate in healthy adult horses and effects on the bone resorption marker CTX-1. (2008) (24)
- Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone. (1997) (24)
- Development of a New ELISA for Serum Periostin: Evaluation of Growth-Related Changes and Bisphosphonate Treatment in Mice (2010) (23)
- Testing of the OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage in Rheumatoid Arthritis: A Systematic Literature Search on 5 Candidate Biomarkers (2009) (23)
- Quantification of HER Expression and Dimerization in Patients’ Tumor Samples Using Time-Resolved Förster Resonance Energy Transfer (2012) (23)
- Estrogen inhibits Dlk1/FA1 production: A potential mechanism for estrogen effects on bone turnover (2011) (22)
- PIIANP and HELIXII diurnal variation. (2008) (22)
- Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial. (2002) (21)
- Three-year follow-up of the use of transdermal 17β-estradiol matrix patches for the prevention of bone loss in early postmenopausal women ☆ ☆☆ (2001) (21)
- Serum Levels of a Cathepsin‐K Generated Periostin Fragment Predict Incident Low‐Trauma Fractures in Postmenopausal Women Independently of BMD and FRAX (2017) (20)
- Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein. (2007) (20)
- Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations. (2010) (19)
- Age-related changes in os calcis ultrasonic indices: A 2-year prospective study (2005) (19)
- A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group. (1999) (18)
- Urinary type II collagen C-terminal peptide is associated with synovitis and predicts structural bone loss in very early inflammatory arthritis (2010) (17)
- Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy. (2008) (16)
- Variability and Response of Urinary Resorption Markers to Hormone Replacement Therapy (1999) (16)
- [Measurement of bone density in the wrist using X-ray absorptiometry: comparison with measurements of other sites]. (1994) (15)
- Osteoarthritis: biological markers for the future? (2002) (14)
- Nitrated type III collagen as a biological marker of nitric oxide-mediated synovial tissue metabolism in osteoarthritis. (2009) (13)
- New biochemical markers of cartilage turnover in osteoarthritis: Recent developments and remaining challenges (2007) (13)
- The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women. (2004) (12)
- Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status. (2019) (12)
- Early effects of zoledronic acid and teriparatide on bone microarchitecture, remodeling and collagen crosslinks: comparison between iliac crest and lumbar vertebra in ewes. (2012) (12)
- Specific effects of anorexia nervosa and obesity on bone mineral density and bone turnover in young women. (2019) (12)
- New biochemical markers of bone turnover (2008) (11)
- Biochemical markers in osteoarthritis: will they measure up? (2006) (11)
- Evaluation of Risk for Osteoporosis Fractures (2002) (10)
- The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis (2018) (10)
- Normalization of bone markers and improved survival during zoledronic acid therapy (2007) (9)
- Association of serum levels of aggrecan ARGS, NITEGE fragments and radiologic knee osteoarthritis in Tunisian patients. (2012) (9)
- Development of an immunoassay for the derived-peptide of chromogranin A, Vasostatin-I (1-76): assessment of severity in patients with sepsis (2012) (9)
- 229 EFFECT OF TREATMENT WITH THE CATHEPSIN-K INHIBITOR, BALICATIB, ON CARTILAGE VOLUME AND BIOCHEMICAL MARKERS OF BONE AND CARTILAGE DEGRADATION IN PATIENTS WITH PAINFUL KNEE OSTEOARTHRITIS (2007) (8)
- Cross-sectional and longitudinal assessment of pre- and postmenopausal bone loss with a portable forearm X-ray device: the Ofely study. (2000) (8)
- Comparison of serum and lithium-heparinate plasma for the accurate measurements of endogenous and exogenous morphine concentrations. (2012) (7)
- Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period (2005) (7)
- Serum levels of receptor activator of nuclear factor kappa-beta (RANK)-ligand (L) and osteoprotegerin (OPG) independently predict long-term radiographic progression in patients with early rheumatoid arthritis (RA) (2003) (7)
- Circulating nitrated N-telopeptide of type III collagen (IIINys) as a biochemical marker of oxidative-related synovial tissue metabolism in rheumatoid arthritis (2009) (7)
- Short‐Term Effects of New Synthetic Conjugated Estrogens on Biochemical Markers of Bone Turnover (2002) (7)
- A routine assay for the direct analysis of HLA-DR-related shared epitope and B27 alleles in chronic inflammatory arthritis. (2001) (7)
- Bone markers--new aspects. (2008) (6)
- Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical Bone (2017) (6)
- Optimal Thresholds, Linear or Nonlinear Relationships of Fracture Risk Reduction With Therapy (2008) (6)
- The cartilage degradation marker, urinary CTX-II, is associated with the risk of incident total joint replacement in postmenopausal women. A 18 year evaluation of the OFELY prospective cohort. (2020) (6)
- Defining a “Reference Population”: No Easy Task (2009) (5)
- New biochemical markers of osteoarthritis (2006) (5)
- [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling]. (2000) (4)
- [Biochemical markers of bone turnover: preanalytical variability and recommendations for use]. (2002) (4)
- [Biochemical markers of bone turnover: preanalytical variability and recommendations for use]. (2002) (4)
- Response to the Letter: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? (2016) (4)
- Three-year follow-up of the use of transdermal 17beta-estradiol matrix patches for the prevention of bone loss in early postmenopausal women. (2001) (4)
- Erratum to: The Role of Collagen Organization on the Properties of Bone (2015) (3)
- COMPARAISON DE DEUX METHODES D'EVALUATION DE LA RATION CALCIQUE ALIMENTAIRE (1993) (3)
- 005 BENEFITS OF MASSIVE WEIGHT LOSS ON SYMPTOMS, SYSTEMIC INFLAMMATION AND CARTILAGE TURNOVER IN OBESE PATIENTSWITH KNEE OSTEOARTHRITIS (2010) (3)
- Fractures and handicap in an adult population: A clinical study. (2007) (3)
- Laboratory Assessment of Postmenopausal Osteoporosis (2006) (3)
- Endogenous morphine-6-glucuronide (M6G) is present in the plasma of patients: validation of a specific anti-M6G antibody for clinical and basic research. (2014) (3)
- Biochemical markers in bone disease (2011) (3)
- Type I collagen isomerization (alpha/beta CTX ratio) and the risk of hip and non-spine fracture in men: A prospective study (2009) (3)
- Effect of bisphosphonate therapies (pamidronate and ibandronate) on the excretion of degradation products of the C-telopeptides of type I collagen measured by a radioimmunoassay (crosslap™ ria) (1995) (2)
- P224 IDENTIFICATION OF EARLY KNEE OSTEOARTHRITIS: RESULTS FROM THE DEVELOPMENT OF A MODEL FOR THE DIAGNOSIS OF EARLY KNEE OSTEOARTHRITIS (MODEKO) STUDY (2006) (2)
- [Biochemical markers of bone remodeling]. (2001) (2)
- Fecal S100A12 levels measured by a new ELISA are increased in ulcerative colitis (UC) and Crohn’s disease (CD) and correlates with intestinal damage (2010) (2)
- Assessment of Bone Turnover in Men Using Biochemical Markers (2010) (2)
- CHAPTER 37 – Laboratory Assessment of Postmenopausal Osteoporosis (2006) (2)
- Bone turnover markers (2020) (2)
- Evaluation of the dimerization profiles of HER tyrosine kinases by time-resolved Förster resonance energy transfer (TR-FRET). (2015) (2)
- Soluble biological markers in osteoarthritis (2021) (2)
- Chapter 8 – Biochemical Markers of Osteoarthritis (2007) (2)
- Biochemical markers of bone turnover: recent data and avenues for the future. (1999) (2)
- 107 BIOLOGICAL VARIABILITY OF BIOCHEMICAL MARKERS OF BONE, CARTILAGE AND SYNOVIAL METABOLISM IN PATIENTS WITH KNEE OSTEOARTHRITIS: EFFECT OF FOOD INTAKE (2007) (2)
- [Comparison of two methods of evaluation of dietary calcium intake]. (1993) (2)
- The role of biochemical markers of joint tissue remodelling to predict progression and treatment efficacy in inflammatory rheumatic diseases. (2020) (2)
- Serum periostin is associated with prevalent knee osteoarthritis and predicts disease progression in women: the OFELY study (2013) (1)
- Immunoassay 25 25 2 Development and Clinical Application in Arthritis of a New Immunoassay for Serum Type IIA Procollagen NH 2 Propeptide (2019) (1)
- 66 A NEW SERUM-BASED ASSAY FOR TYPE II COLLAGEN HELICAL PEPTIDE (SERUM HELIX-II) IS ASSOCIATED WITH LONG-TERM RADIOLOGICAL PROGRESSION IN KNEE OSTEOARTHRITIS (2007) (1)
- Periostin as a circulating marker for breast cancer bone metastases (2011) (1)
- Biochemical markers of bone and cartilage in osteoarthritis (2004) (1)
- Towards a toolkit for the assessment and monitoring of musculoskeletal ageing (2018) (1)
- Human Nutrition and Metabolism The DASH Diet and Sodium Reduction Improve Markers of Bone Turnover and Calcium Metabolism in Adults 1 , 2 (2003) (1)
- Relationships between osteoporosis medication adherence, surrogate marker outcomes and non-vertebral fracture incidence (2010) (1)
- P94 NITROSYLATED N-TELOPEPTIDE OF TYPE III COLLAGEN (IIINYS): A NEW SPECIFIC BIOCHEMICAL MARKER OF OXIDATIVE-INDUCED SYNOVIAL TISSUE METABOLISM IN ARTHRITIS (2006) (1)
- Zoledronic acid safety and efficacy over 5 years in postmenopausal osteoporosis (2006) (1)
- BIOCHEMICAL MARKERS ARE ASSOCIATED WITH RADIOGRAPHIC SUBTYPES OF OSTEOARTHRITIS IN SUBJECT WITH FAMILIAL OA AT MULTIPLE SITES. THE GARP STUDY (2007) (1)
- Development of a new ELISA for serum periostin: Growth-related changes and effects of bisphosphonate in mice (2009) (1)
- [Prescription of bone remodeling markers in hospitals]. (2002) (1)
- 93 SERUM DICKKOPF-1 (DKK-1) LEVELS ARE INCREASED IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS, BUT DECREASED IN PATIENTS WITH KNEE OSTEOARTHRITIS AND ARE ASSOCIATED WITH CARTILAGE AND SYNOVIAL TISSUE TURNOVER (2008) (0)
- Undercarboxylated osteocalcin (uc OC) measured with a direct and specific immunoassy predicts hip fracture (fx) in elderly women. The epidos prospective study (2006) (0)
- Methods for evaluation of cartilage degradation (2005) (0)
- A39 ALTERED BONE TYPE I COLLAGEN TURNOVER AND MATURATION ARE ASSOCIATED WITH INCREASED CARTILAGE DEGRADATION IN PATIENTS WITH OSTEOGENESIS IMPERFECTA (OI) (2008) (0)
- Procedures for diagnosing a synovial or osteoarticular pathology. (2000) (0)
- Cathepsin K Preferentially Solubilizes Matured Bone Matrix (2012) (0)
- Serum Col3-4: A new type III and IV collagen biochemical marker of synovial tissue turnover in patients with rheumatoid arthritis (2023) (0)
- [Iron pathology in pregnancy]. (1987) (0)
- Correction (2009) (0)
- Estrogen inhibits DLK1/FA1/PREF-1 production: A potential mechanism for estrogen effects on bone and cartilage turnover (2008) (0)
- 120 CARTILAGE BIOMARKERS IN URINE – ANALYSIS AFTER ANTERIOR CRUCIATE LIGAMENT TRANSECTION (2007) (0)
- Biomarkers of Disease: The clinical application of biomarkers in osteoporosis (2002) (0)
- Committees and Contact Information (2007) (0)
- Measurement of bone resorption in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen (2006) (0)
- A method for the diagnosis of osteoarticular diseases or synovial (2000) (0)
- Association of biomarkers with osteoarthritis progression based on MRI: results from the Vancouver knee osteoarthritis progression (KOAP) study (2013) (0)
- [Iron pathology in non-pregnant women]. (1987) (0)
- Effect of hormonal replacement therapy withdrawal on bone mass and bone turnover The OFELY study (2000) (0)
- osteoarthritis at multiple sites: the GARP study hand, and facet joints in subject with familial radiographic subtypes of osteoarthritis in hip, knee, Urinary CTX-II levels are associated with (2006) (0)
- Erratum to “Periostin as a circulating marker for breast cancer bone metastases” [Bone 47S2 (2010) S328–S329] (2011) (0)
- Sequences, antibodies, and processes required for the detection and assay in vitro periostin, for diagnosis monitoring or prognosis of diseases or biological phenomena involving periostin (2009) (0)
- P106 BIOMARKERS DEMONSTRATE DEGRADATION AND INFLAMMATION AS CHARACTERISTICS OF IDIOPATHIC OSTEOARTHRITIS (OA) (2006) (0)
- Multimarker approach for linking bone disorders and cardiovascular events in Chronical Kidney Disease (CKD) (2009) (0)
- A343 Rapid Stimulation of Bone Formation by Bortezomib in Multiple Myeloma (2009) (0)
- Effects of Nine Hemoglobin Variants on Five Glycohe (2000) (0)
- Changes of body composition (fat and lean mass) with age and menopause (MP). The ofely cohort (2006) (0)
- Vitamin D receptor genotype and bone turnover in female twins (2006) (0)
- Prediction of Disease Outcome With Quantitative Measurement of HER-2 Receptor Expression and Dimerization in Patients With Breast Cancer (2012) (0)
- 113 ANALYSIS OF 31 BIOMARKERS AND BIOMARKER FACTORS IN PRE-RADIOGRAPHIC AND RADIOGRAPHIC KNEE OSTEOARTHRITIS: RESULTS OF A POPULATION-BASED STUDY USING MRI (2009) (0)
- Effect of bisphosphonate treatment on the urinary excretion of C-telopeptide degradation products of type I collagen measured in the crosslaps⊥M ELISA (1995) (0)
- Serum sclerostin is not associated with knee osteoarthritis prevalence and progression of kellgren-lawrence score in women: the ofely study (2014) (0)
- Assessment of serum bone alkaline phosphatase activity with a new elisa using a specific monoclonal antibody (2006) (0)
- Modalities of prescription of biochemical markers of bone turnover in french hospitals (2002) (0)
- High Dose Simvastatin Has No Beneficial Effect on Markers of Bone Turn-Over in Multiple Myeloma. (2007) (0)
- [Possibility of pharmacologic intervention in iron-deficiency pathology in pregnancy]. (1987) (0)
- Methods and kits for the diagnosis or monitoring of a synovial or osteoarticular pathology comprising the use of a marker specific for the degradation of synovial tissue (1999) (0)
- The proteasome inhibitor bortezomib overcomes the inhibition of osteoblast function observed in multiple myeloma (2010) (0)
- A specific two-site radioimmunoassay for intact human osteocalcin (1992) (0)
- Radiographic knee osteoarthritis presence and severity is associated with the urinary biochemical markers CTX-II and glucosyl-galactosyl-pyridinoline (2005) (0)
- 116 NITRIC OXIDE-INDUCED ALTERATIONS OF SYNOVIAL TISSUE IN KNEE OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS IS REFLECTED BY INCREASED JOINT FLUID AND CIRCULATING LEVELS OF NITROSYLATED N-TELOPEPTIDE OF TYPE III COLLAGEN (IIINYS) (2007) (0)
- Biochemical Markers of Osteoarthritis (2004) (0)
- Erratum to: The Role of Collagen Organization on the Properties of Bone (2015) (0)
- P109 CHARACTERISATIONOF CARTILAGE TYPE II COLLAGEN DEGRADATION IN THE RABBIT ACLT MODEL (OA) LOAD (2006) (0)
- Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical Bone (2017) (0)
- Combination of a marker of bone resorption, bone density and ultrasound parameters improves the prediction of hip fracture in the elderly: The epidos prospective study (2006) (0)
- ASBMR 25th Annual Meeting 1001–1222 (2003) (0)
- P108 TQOL-LITE: A SIMPLIFIED ASSESSMENT TOOL FOR TOTAL QUANTITATIVE OSTEOARTHRITIS (OA) LOAD (2006) (0)
- independently of osteoclastic activation in men A bout of resistance exercise increases urinary calcium (2015) (0)
- 110 CIRCULATING LEVELS OF AGGRECANASE-DERIVED AGGRECAN FRAGMENTS ARE ELEVATED IN PATIENTS WITH RHEUMATOID ARTHRITIS, HOWEVER, CORRESPONDING MMP-DERIVED FRAGMENTS ARE NOT (2009) (0)
- Chapter 10 – Biochemical Markers of Bone Turnover (2006) (0)
- The Role of Collagen Organization on the Properties of Bone (2015) (0)
- Method for assessing in a subject bruskvævsnedbrydning (2005) (0)
- PrognosticValue of PINP , BoneAlkaline Phosphatase , CTX-I , andYKL-40 in PatientsWithMetastatic ProstateCarcinoma (2006) (0)
- P 109 CHARACTERISATION OF CARTILAGE TYPE II COLLAGEN DEGRADATION IN THE RABBIT ACLT MODEL (2007) (0)
- Clinical markers of osteoarthrosis analyzed under the microscope (2007) (0)
- The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis (2018) (0)
- The Utility of Biomarkers in Osteoporosis Management (2017) (0)
- P-87. Changes in Bone Mineral Density and Serum Cholesterol in Osteoporotic Postmenopausal Women Treated with Raloxifene (1998) (0)
- The ankylosing spondylitis disease activity score (ASDAS) better reflects the inflammatory disease processes than BASDAI - a comparison with biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF-blockers (2010) (0)
- urinary CTX-II predicts the risk of total joint replacement in postmenopausal women: a 18-year longitudinal study (2020) (0)
- Associations of clinical and biomarker variables with cartilage damage in painful pre-radiographic knee osteoarthritis. results from a population-based study (2013) (0)
- THERANOSTIC method based on the detection of dimers her2-her2 (2012) (0)
- Glucocorticoids Attenuate the Stimulatory Effect on Bone Formation by Bortezomib (2008) (0)
- AFPL-67. Zoledronic acid safety and efficacy over 5 years in post-menopausal osteoporosis (2007) (0)
- Plasma crtac-1 measured by elisa, predicts the progression to total joint replacement, independently of urinary ctx-ii, in postmenopausal women (2023) (0)
- Hand osteoarthritis is associated with increased type II collagen degradation in women: the OFELY study (2013) (0)
- Significant bone loss at the hip in women under hormone replacement therapy (HRT) for more than 4 years. The ofely prospective study (2006) (0)
- PL8.2. Use of biochemical markers to monitor therapy in metastatic bone disease (2008) (0)
- List of Contributors (2020) (0)
- Sequences, antibodies, methods and kits for the detection and determination in vitro of periostin, for the diagnosis or monitoring of prognosis of pathologies or biological phenomena involving periostin (2009) (0)
- P83 CONTRIBUTION OF MATRIX METALLOPROTEINASES (MMPS) AND CYSTEINE PROTEASES IN OSTEOARTHRITIS (OA) CARTILAGE DEGRADATION: AN EX-VIVOHUMAN CARTILAGE EXPLANT APPROACH USING THE TYPE II COLLAGEN FRAGMENTS HELIX-II AND CTX-II (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Patrick Garnero?
Patrick Garnero is affiliated with the following schools:
